Biotech

All Articles

Lilly- backed weight reduction biotech data IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' cannabis usage medicine flunks stage 2b, driving Indivior to reassess $100M possibility

.Aelis Farma's hopes of securing a fast, good choice on a $one hundred thousand alternative settleme...

ProKidney stops period 3 test certainly not needed for tissue treatment confirmation

.ProKidney has stopped some of a set of stage 3 tests for its own cell treatment for kidney conditio...

Vaxcyte climbs on 'stunning' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what professionals called "magnificent" period 1/2 data for its own 31-valent pn...

Recursion's mind illness test presents insufficient evidence of efficiency

.Recursion has actually stumbled through an early test of its tech-enabled strategy to medicine reve...

Acepodia, Pfizer click together for chemistry-based tissue therapy

.Call it a case of good chemistry: Acepodia, a biotech based upon Nobel Prize-winning scientific res...

Praxis epilepsy drug decreases seizures in period 2 trial

.Practice Accuracy Medicines has actually racked up one more midphase win in epilepsy this year, alo...

Three execs surrender as Dyne articles blended information for DMD prospect

.After getting away from a scientific grip numerous years back, Dyne Rehab has actually exposed new ...

Arrowhead fires off phase 3 records in rare metabolic ailment before market encounter Ionis

.Arrowhead Pharmaceuticals has presented its hand before a prospective face-off with Ionis, releasin...

Pfizer, Valneva present lyme disease chance reliable for second booster

.Pfizer and Valneva might possess concerning two even more years to wait prior to they make the 1st ...